Party In The USA (Bankruptcy Courts)

Yesterday we heard that Bed Bath and Beyond is concerned about its future. And today, another struggling retailer joined the mix, expressing concerns of its own. ⚠️

Party City announced today that it’s preparing to file for bankruptcy within weeks. Like Bed Bath & Beyond, it’s burned through its cash trying to turn the company around. However, sales have remained weak and pressured by inflation and the softening economy.

The low-interest rate environment and strong stock market of the last decade helped buoy a lot of bad businesses. But the quickly turning tides of 2022 mean they can no longer tread water and company executives are forced to face the music.

Many analysts expect this won’t be the last bankruptcy filing we hear of in 2023. On the contrary, many of them believe the bankruptcy *party* may be just getting started. 🥁

$PRTY shares fell 50% to new all-time lows on the news. 📉

Justice Department Targets UnitedHealth

With the upcoming presidential election looming, the current administration is itching to accomplish more before a potential shakeup. While antitrust regulators have had a field day with big tech, airlines, grocery chains, and others this year, they’re taking another look at UnitedHealth, especially given its recent cybersecurity issues. 🕵️‍♂️

The Justice Department is poking around to figure out the relationship between the company’s UnitedHealthcare insurance unit and its Optum health-services division. They’ve asked how UnitedHealth’s acquisitions of doctor groups might affect competitors and consumers. 🤔

Read It

Biotech Buyout Spree Continues

It may be the last week of the year, but many companies are rushing to get deals done before year-end. Two significant transactions in the biotech space were announced today, so let’s dive in. 👇

The first deal involves RayzeBio, which raised $358 million via an initial public offering (IPO) just three months ago. However, its time as a public company is being cut short by Bristol Myers Squibb, which is acquiring the radiopharmaceutical therapeutics company for $62.50 per share in cash. 💰

Read It

What’s With All The Accounting Issues?

Accounting is the practice of using numbers to tell the story of a company’s past, present, and future. For an investor, these numbers and stories are the foundation of all decisions, so it’s imperative that they’re done correctly. And generally, they are.

But lately, there’s been an uptick in the number of accounting mishaps making their way into the financial markets. Today we got a few more instances of this problem, so let’s take a look. 📝

Read It

Only Some EV-Makers Delivered

Electric vehicle (EV) manufacturers came out with their fourth-quarter delivery numbers today, sending their stocks all over the place. 📊

First, let’s start with everyone’s favorite, Tesla, which delivered mixed news to investors. It managed 1.81 million EV deliveries around the globe in 2023, meeting its full-year guidance and narrowly topping the consensus estimates. That was up 38% YoY but slowed from 2022. 

Read It